Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study (Q42658845)
Jump to navigation
Jump to search
scientific article published on September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study |
scientific article published on September 2010 |
Statements
1 reference
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study (English)
1 reference
Daniel Podzamczer
1 reference
Frank A Post
1 reference
Graeme J Moyle
1 reference
Hans Jürgen Stellbrink
1 reference
Pere Domingo
1 reference
Martin Fisher
1 reference
Anthony G Norden
1 reference
Armin Rieger
1 reference
Marie-Aude Khuong-Josses
1 reference
Teresa Branco
1 reference
Naomi Givens
1 reference
Cindy Vavro
1 reference
Michael L Lim
1 reference
1 September 2010
1 reference
1 reference
Identifiers
1 reference